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ABSTRACT
Adaptation of the viral polymerase complex comprising PB1, PB2, and PA is necessary for efficient influenza A virus replication
in new host species. We found that PAmutation K356R (PA-K356R) has become predominant since 2014 in avian H9N2 viruses
in China as with seasonal humanH1N1 viruses. The samemutation is also found in most human isolates of emergent avian
H7N9 and H10N8 viruses whose six internal gene segments are derived from the H9N2 virus. We further demonstrated the
mammalian adaptive functionality of the PA-K356Rmutation. Avian H9N2 virus with the PA-K356Rmutation in human A549
cells showed increased nuclear accumulation of PA and increased viral polymerase activity that resulted in elevated levels of viral
transcription and virus output. The samemutant virus in mice also enhanced virus replication and caused lethal infection. In
addition, combinedmutation of PA-K356R and PB2-E627K, a well-knownmammalian adaptive marker, in the H9N2 virus
showed further cooperative increases in virus production and severity of infection in vitro and in vivo. In summary, PA-K356R
behaves as a novel mammalian tropismmutation, which, along with other mutations such as PB2-E627K, might render avian
H9N2 viruses adapted for human infection.
IMPORTANCE
Mutations of the polymerase complex (PB1, PB2, and PA) of influenza A virus are necessary for viral adaptation to new hosts.
This study reports a novel and predominant mammalian adaptive mutation, PA-K356R, in avian H9N2 viruses and human iso-
lates of emergent H7N9 and H10N8 viruses. We found that PA-356R in H9N2 viruses causes significant increases in virus repli-
cation and severity of infection in human cells andmice and that PA-K356R cooperates with the PB2-E627Kmutation, a well-
characterized human adaptive marker, to exacerbate mammalian infection in vitro and in vivo. Therefore, the PA-K356R
mutation is a significant adaptation in H9N2 viruses and related H7N9 and H10N8 reassortants toward human infectivity.
The emergence of new pandemic influenza A viruses requiresovercoming barriers to cross-species transmission from ani-
mal reservoirs to human populations. Influenza viruses of the
H9N2 subtype and their reassortants circulating in poultry are a
potential source of pandemic viruses and hence represent a signif-
icant public health threat (1). Since spring 2013, a novel avian
H7N9 reassortant with six internal genes of the H9N2 virus had
caused threemajor outbreaks in humans throughout China (2, 3).
During the same period, a newly emergent avian H10N8 virus,
also with six H9N2-like internal genes, was reported to cause fatal
human infections in China (4). In the meantime, H9N2 viruses
continued to cause human infections in China and other coun-
tries based on etiological and serological evidence (5–12). We re-
cently found that avian H9N2 viruses have undergone significant
genetic evolution, especially in their internal genes, to form a pre-
dominant genotype (G57), which in turn provided the internal
genes to multiple new subtypes, including H7N9 and H10N8 vi-
ruses (13). Thus, the evolving internal genes of H9N2 viruses may
be a primary genetic source for emergent H9N2 viruses and their
reassortants that can confer human infection. Understanding the
mechanisms by which influenza viruses acquire the ability to in-
fect multiple host species is therefore imperative to managing fu-
ture outbreaks.
Adaptation of viral polymerase is necessary for efficient virus
replication in a new host species (14). The viral polymerase com-
plex of the PB1, PB2, and PA proteins assembles with viral RNA
and nucleoprotein (NP) to undertake transcription and replica-
tion of the viral genome (15). Polymerases of avian origin gener-
ally have impaired activity in human and other mammalian cells
(16–21). To overcome this natural restriction, avian polymerases
need to acquire mutations that lead to improved activity in mam-
malian hosts. For instance, the well-characterized PB2 mutation
E627K (PB2-E627K) mediates a clear preferential switch in en-
hanced polymerase activity, virus replication, transmission, and,
in certain cases, pathogenicity in mammals (22). Furthermore,
several other residues, such as PB2-590S/591R, -701N, -591K, and
-271A, have been described to increase viral polymerase activity
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and contribute to increased virus replication and pathogenicity in
mammals (16, 23, 24).
PA amino acid residues 224S, 70V, 85I, 86S, 336M, 353R, and
552S are found to contribute to the viral polymerase activity of
H1N1/2009, avian H3N2, or H5N1 viruses in mammalian cells
that results in enhanced virus replication and pathogenicity in
mammals (25). However, little is known about host adaptive mu-
tations in the PA protein of avian H9N2 influenza viruses. Re-
cently, comprehensive phylogenetic and ancestral inference anal-
yses revealed a number of amino acid changes of avian H9N2
viruses, including K356R of PA, whichmay contribute to the evo-
lutionary path of H7N9 viruses in humans (26). By analyzing the
sequence and crystal structure of the PA subunit, Xu et al. also
hypothesized that PA-356R is a possible signature of avian H7N9
viruseswith bird-to-human transmissibility (27). Yamayoshi et al.
tested the adaptive functionality of PA-K356R by reversing the
mutation (from a human-like residue to an avian-like residue) to
PA-R356K in the context of a human-derived H7N9 virus, which
appeared to have little effect on viral polymerase activity and vir-
ulence in vitro and in vivo (28).However, the role of the PA-K356R
mutation in H9N2 viruses in species tropism and pathogenicity
remains far from clear. In this study, we investigated the emer-
gence of the PA-K356R mutation in avian H9N2, H7N9, and
H10N8 viruses as well as human H1N1 influenza viruses. We
found that PA-K356R has recently emerged in PA of H9N2 avian
influenza viruses (AIVs) to become predominant and has been
passed on by reassortment to H7N9 andH10N8 viruses. PA-356R
and PB2-627K extensively coexist in H7N9 and H10N8 isolates
from human rather than avian hosts, which suggests human tro-
pism. Furthermore, PA-K356R inH9N2 viruses showed indepen-
dent and cooperative effects with PB2-E627K of enhanced repli-
cation and severity of infection in mammalian cells and mice.
MATERIALS AND METHODS
Ethical compliance. All animal work was approved by the Beijing Asso-
ciation for Science and Technology (approval SYXK [Beijing] 2007-0023)
and conducted in accordance with Beijing Laboratory Animal Welfare
and Ethics guidelines, as issued by the Beijing Administration Committee
of Laboratory Animals, and in accordance with China Agricultural Uni-
versity (CAU) Institutional Animal Care and Use Committee guidelines
(SKLAB-B-2010-003).
Viruses, plasmids, and cells. The use of the wild-type (WT) H9N2
virus A/chicken/Hebei/LC/2008 (HB08) was described previously (29).
pcDNA-PB1, pcDNA-PB2, pcDNA-PA, and pcDNA-NP protein expres-
sion plasmids for the three polymerase subunits and NP of influenza
HB08 virus were generated by subcloning of the corresponding coding
segments into the pcDNA3.1 vector. Human embryonic kidney (293T)
cells, human pulmonary adenocarcinoma (A549) cells, Madin-Darby ca-
nine kidney (MDCK) cells, and chicken fibroblast (DF-1) cells weremain-
tained in Dulbecco’s modified Eagle’s medium (DMEM; Gibco) supple-
mentedwith 10% fetal bovine serum (FBS; Gibco), 100U/ml of penicillin,
and 100 g/ml of streptomycin at 37°C in a 5% CO2 atmosphere.
Generation ofmutant viruses by reverse genetics.All eight gene seg-
ments amplified by reverse transcription-PCR (RT-PCR) from the HB08
virus were individually cloned into a dual-promoter plasmid, pHW2000
(29). Mutations K356R and E627K were introduced into the PA and PB2
genes, respectively, by using a site-directed QuikChange mutagenesis kit
(Agilent, Santa Clara, CA) according to the manufacturer’s instructions.
Primer sequences are available upon request. The rescued viruses possess-
ing the single mutations PA-K356R and PB2-E627K and the combined
mutations (double mutant) PA-K356R and PB2-E627K were designated
PA-K356R, PB2-E627K, and PA-K356R/PB2-E627K, respectively. The
WT HB08 virus, the PA-K356R and PB2-E627K single mutant viruses,
and the PA-K356R/PB2-E627K double mutant virus were generated by
reverse genetics as previously described (29). Viral RNAwas extracted and
amplified by RT-PCR, and each viral segment was sequenced to confirm
the mutational identity of each virus.
Virus detection by immunofluorescence. A549 cells were grown on
glass-bottom dishes and infected with the indicated viruses at a multiplic-
ity of infection (MOI) of 2.0. At the specified time points postinfection,
the cells were fixed with 4% paraformaldehyde in phosphate-buffered
saline (PBS) for 30min and permeabilized with 0.5%Triton X-100 in PBS
for 30 min. After blocking with 5% bovine serum albumin (BSA) in PBS,
the cells were incubated with rabbit antisera against PA (GeneTex, USA)
for 12 h at 4°C. The cells were then washed three times with PBS and
incubated with fluorescein isothiocyanate (FITC)-coupled goat anti-rab-
bit (Abcam, United Kingdom) secondary antibodies for 1 h at 37°C. The
cells were subsequently washed three times with PBS and incubated with
4=,6-diamidino-2-phenylindole (DAPI) for 10 min. Cells were imaged
with a laser scanning confocal microscope (Leica). The frequency of nu-
clear localization of the PA protein was determined by cell counting (n
100).
Viral ribonucleoprotein polymerase assay. Ribonucleoprotein
(RNP) polymerase (minigenome luciferase) assays were based on the
cotransfection of four pcDNA3.1 expression plasmids harboring PB2,
PB1, PA, and NP (125 ng each) from individual H9N2 recombinant vi-
ruses (WT, PA-K356R, PB2-E627K, and PA-K356R/PB2-E627K) into hu-
man 293T or chicken DF-1 cells, together with a pYH-NS1-Luci plasmid
expressing a reporter firefly luciferase gene under the control of the hu-
man or chicken RNA polymerase I promoter (10 ng) and an internal
control plasmid expressing renilla luciferase (2.5 ng). Cultures were incu-
bated at 33°C, 37°C, or 39°C. After 24 h of transfection, cell lysates were
prepared with the Dual Luciferase Reporter Assay system (Promega), and
luciferase activity was determined with a GloMax 96 microplate lumi-
nometer (Promega).
Western blotting.Total cell protein lysates were extracted from trans-
fected 293T or DF-1 cells with radioimmunoprecipitation assay (RIPA)
lysis buffer, and the total protein concentration was determined by using
a bicinchoninic acid (BCA) protein assay kit (Beyotime, China). In nu-
clear import experiments with plasmids, cytoplasmic and nuclear frac-
tions of cell lysates were separated by using a nuclear and cytoplasmic
extraction kit (Beyotime, China) according to themanufacturer’s instruc-
tions. Protein samples derived from cell lysates were heated at 100°C for
10 min and then separated on a 12% sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) gel, transferred onto a polyvi-
nylidene difluoride (PVDF) membrane (Bio-Rad, USA), and subse-
quently incubated with a primary antibody. Primary antibodies were
specific for influenzaA virus PA (diluted 1:3,000; GeneTex,USA) andPB2
(diluted 1:3,000; Thermo Fisher, USA), -actin (diluted 1:5,000; Beyo-
time, China), or PCNA (diluted 1:2,000; Abcam, United Kingdom). The
secondary antibody used was horseradish peroxidase (HRP)-conjugated
anti-rabbit or -mouse antibody (diluted 1:10,000; Beyotime, China).HRP
was detected by using a Western Lightning chemiluminescence kit (Am-
ersham Pharmacia, Freiburg, Germany) according to the manufacturer’s
protocols.
Quantitative real-time PCR. Levels of mRNA and viral RNA (vRNA)
were determined in A549 cells infected with different H9N2 viruses at an
MOI of 1.0 or 0.01. Total RNA was extracted from infected A549 cells by
using TRIzol reagent according to themanufacturer’s instructions (Invit-
rogen). For the detection of mRNA and vRNA, the oligo(dT) primer and
primer uni-12 (5=-AGCAAACGACC-3=), respectively, were used to gen-
erate cDNAs with 1 g of total RNA per sample by using Superscript III
first-strand synthesis supermix (Invitrogen). The quantitative real-time
PCR (qRT-PCR) mixture for each reaction sample consisted of 10 l of
2 SYBR green PCR master mix (Applied Biosystems), 7 l of nuclease-
free water, 0.5 l of each primer, and 2 l of the cDNA template. mRNA
and vRNA expression levels for the -actin, matrix protein (M1), and
Xu et al.
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nucleoprotein (NP) genes were quantified by using the 7500 real-time
PCR system (Applied Biosystems) with the following program: 1 cycle at
95°C for 10min, followed by 40 cycles of 95°C for 15 s and 60°C for 1min.
Expression values for each gene, relative to -actin, were calculated by
using the 2CT method. Each experiment contained three technical
replicates for each sample, and two experimental replicates were per-
formed. Primers for the amplification of the -actin, M1, and NP genes
are as follows: forward primer 5=-AGAGCTACGAGCTGCCTGAC-3=
and reverse primer 5=-CGTGGATGCCACAGGACT-3= for -actin, for-
ward primer 5=-CGCACAGAGACTTGAGGATG-3= and reverse primer
5=-TGGGTCTCCATTCCCATTTA-3= for M1, and forward primer 5=-
CAGTGAAGGGGATAGGGACA-3= and reverse primer 5=-CCAGGATT
TCTGCTCTCTCG-3= for NP.
Virus titration and replication kinetics. The 50% tissue culture in-
fectious dose (TCID50) was determined in MDCK cells with 10-fold seri-
ally diluted viruses inoculated at 37°C for 72 h. The TCID50 value was
calculated by the Reed-Muenchmethod (30).Multistep replication kinet-
ics was determined by inoculating MDCK or A549 cells with viruses at an
MOIof 0.001 or 0.01, respectively. After 1 h of incubation at 37°C, the cells
were washed twice and further incubated in serum-free DMEM contain-
ing 1.0 g/ml tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)
trypsin. Supernatants were sampled at 6, 12, 24, 36, 48, 60, and 72 h
postinoculation (hpi). Analysis of single-replication-cycle kinetics was
similarly conducted except with a starting inoculation at an MOI of 1.0.
Supernatants were sampled at 2, 4, 6, 8, 10, and 12 hpi. All collected
supernatants were titrated on MDCK cells in 96-well plates; three inde-
pendent experiments were performed.
Mouse challenge study. Fourteen mice (6-week-old female BALB/c
mice; Vital River Laboratory, Beijing, China) per group were anesthetized
with tiletamine-zolazepam (Zoletil; Virbac SA, Carros, France) (20mg/g)
and inoculated intranasally with 50 l of 106 TCID50 of each test virus
diluted in PBS. Five mice from each group were monitored daily for 14
days, and mice that lost 30% of their original body weight were hu-
manely euthanized. Three mice from each group were euthanized at 1, 3,
and 5 days postinoculation (dpi) for the determination of virus titers,
histology, and cytokine levels. Lungs and nasal turbinates were collected
and homogenized in 1 ml of cold PBS. Virus titers were determined by a
TCID50 assay. A portion of the lung from each euthanized mouse at 5 dpi
was fixed in 10% phosphate-buffered formalin for histopathological ex-
amination, which was performed as described previously (31).
Quantification of cytokines in murine lungs. Levels of cytokine pro-
teins, including tumor necrosis factor alpha (TNF-	), interleukin-6 (IL-
6), and interleukin-1 beta (IL-1), were determined by a using cytometric
bead array method (BD Cytometric Bead Array mouse inflammation kit;
FIG 1 Prevalence of amino acid residues PA-356K and PA-356R in seasonal human H1N1 and avian H9N2 influenza viruses (A) and prevalence of PA-356R
alone or PA-356R/PB2-627K in H7N9 and H10N8 influenza viruses during 2013 to 2014 (B). For each column from left to right, the actual numbers of viruses
are 22, 21, 1,320, 138, 590, 84, 101, 241, and 29, respectively (A) and 399, 77, 399, 77, 54, 2, 54, and 2, respectively (B). In panel A, the proportion of viruses with
PA-356R (0.33%) or other residues (0.30%) is too low to be seen between 2001 and 2010. In panel B, “Others” refers to viruses without the two residues PA-356R
and PB2-627K; the number of influenza viruses with PA-356R/PB2-627K is 2 for avian H7N9 viruses.
FIG 2 Nuclear import of PA proteins of H9N2 viruses. (A) Nuclear localiza-
tion of the PA protein in A549 cells infected withH9N2 viruses. PA proteins in
A549 cells infected with the indicated H9N2 viruses at an MOI of 2.0 were
localized by immunofluorescence (green) at 4, 6, 8, and 10 hpi. Nuclei were
stained with DAPI (blue). (B) Relative nuclear localization of PA protein. A
hundred cells (blue nuclei) permicroscopic fieldwere randomly selected, from
which the percentage of intranuclear PA (green) was determined. Data are
presented as means 
 standard deviations of results from three independent
experiments. * indicates that the value is significantly different from that for
the wild-type virus (P 0.05 as determined by ANOVA). (C) Protein levels of
the PA protein in the cytoplasm and nucleus of transfected 293T cells. 293T
cells were transfected with a plasmid expressing wild-type PA (PA-WT) or a
PA mutant (PA-K356R). Cells were harvested 24 h later, and the expression
levels of cytoplasmic and nuclear PA protein were detected by immunoblot-
ting. PA-N and PA-C represent the expression levels of PA in the nucleus and
cytoplasm, respectively. The density of each band on the immunoblot was
normalized to the density of -actin in the cytoplasm or PCNA in the nucleus.
PA-K356R in H9N2 Avian Inﬂuenza Virus
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BD Bioscience, San Diego, CA, USA). Briefly, a 50 l of a mouse inflam-
mation capture bead suspension and 50 l of detection reagent were
added to an equal amount of sample, and the sample was incubated in the
dark for 2 h at room temperature. Subsequently, each sample was washed
with 1 ml wash buffer and then centrifuged at 200 g at room tempera-
ture for 5 min. Supernatants were discarded, and a further 300l of wash
buffer was added. Samples were analyzed on a BD fluorescence activated
cell sorting (FACS) Array bioanalyzer (BD Bioscience). Data were ana-
lyzed by using BD CBA software (BD Bioscience). Levels of each cytokine
were computed as picograms per milliliter of homogenate.
Statistical analyses. All statistical analyses were performed by using
GraphPad Prism software version 5.00 (GraphPad Software Inc., San
Diego, CA, USA). Statistically significant differences between experimen-
tal groups were determined by analysis of variance (ANOVA). Differences
were considered statistically significant at a P value of0.05.
RESULTS
Potential mammalian adaptive mutation K356R is predomi-
nant in the PA protein of avian H9N2 virus. Previous computa-
tional studies suggested that K356R in PA is a potential mamma-
lian adaptive mutation (27). The PA-356R residue is conserved
among pandemic H1N1/2009 (pH1N1/2009) and seasonal hu-
man H1N1/H2N2/H3N2 viruses but is rarely found in avian in-
fluenza viruses (27). Our sequence searches revealed an adaptive
mutation trace of PA-K356R in seasonal human H1N1 influenza
viruses (Fig. 1A). The human-like signature of PA-356R had
steadily replaced the avian-like PA-356K signature from the early
prevalence of avian-origin H1N1 viruses in humans from 1918 to
1976 to become the predominant mutation in 1977 to 2008. Co-
incidentally, we found that all avian H9N2 strains isolated in 2014
in China, unlike previous years, also carried the human-like resi-
due PA-356R (Fig. 1A). The percentage of H9N2 viruses with
PA-356R had increased sharply from 4.76% in 2011 to 100% in
2014. H9N2 viruses before 2010 were nearly all avian-like PA-
356K viruses. As H9N2 viruses provide six internal genes to emer-
gent H7N9 and H10N8 viruses that have been causing severe
human infections since 2013, we examined the prevalence of PA-
356R in avian- and human-derived H7N9/H10N8 strains. As
shown in Fig. 1B, human H7N9 and H10N8 isolates showed
higher frequencies of human-like residue 356R than did avian
H7N9 and H10N8 isolates. Furthermore, the proportion of hu-
man H7N9 isolates with both PA-356R and PB2-627K was much
higher than that of the corresponding avian isolates. With further
screening of H9N2 viruses, we also found the coexistence of PA-
K356R and PB2-E627K mutations in two naturally occurring
avian H9N2 isolates (A/chicken/Jinan/3952/2013 and A/chicken/
Jinan/4225/2013). These findings suggest that the PA-K356Rmu-
tation in avian H9N2 viruses, by itself or in coordination with
PB2-E627K, might confer an adaptive change to the polymerase
complex of avian influenza virus for cross-species transmission to
facilitate virus replication and/or pathogenicity in humans. The
biological contribution of the PA-K356Rmutation toH9N2 avian
influenza virus is not known.
PA-K356R increases nuclear accumulation of PA protein.
During influenza virus replication, the PA protein, synthesized in
the cytoplasm, is imported into the nucleus to form a functional
polymerase complex with PB2, PB1, andNP (15).We determined
if the K356Rmutation in the PA protein affects the nuclear trans-
port of PA. Human A549 cells were infected with parental WT
(HB08) and mutant PA-K356R viruses at an MOI of 2.0, and the
cellular localization of PA was determined at different time points
postinfection (Fig. 2A and B). For each virus, the accumulation of
PA beyond 4 h of infection shifted from the cytoplasm to the
nucleus. However, PA from the mutant virus showed a signifi-
FIG 3 RNP polymerase activities of wild-type and mutant H9N2 influenza viruses. Polymerase activities in 293T cells (A) or DF-1 cells (B) were determined by
minigenome replication assays and are expressed as mean percent activities
 standard deviations, with the activity of the corresponding wild-type PA protein
being set at 100% from three independent experiments. Western blotting was performed on protein lysates from 293T or DF-1 cells transfected with wild-type
andmutant polymerase plasmids (PA and PB2). The density of each band on the immunoblot was normalized to the density of-actin. * indicates that the value
is significantly different from that for the wild-type virus (P 0.05 as determined by ANOVA), and # indicates that the value is significantly different from that
for the virus with single mutation PB2-E627K (P 0.05 as determined by ANOVA).
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cantly higher rate of nuclear accumulation at 6, 8, and 10 hpi than
the corresponding WT virus (P  0.05). To further determine
whether the enhanced nuclear import was the result of an increase
in PA-K356R protein nuclear affinity, Western blotting was per-
formed to detect the relative distribution of PA in the cytoplasmic
and nuclear compartments of transfected (WTPA and PA-K356R
expression plasmids) human 293T cells (Fig. 2C). WT PA and
PA-K356R protein levels were similarly detected in each compart-
ment. Thus, the increase in the nuclear entry rate of PA-K356R
relative to that of WT PA during infection (Fig. 2A and B) was
likely the result of increased viral replication rather than a change
in its nuclear affinity (Fig. 2C).
PA-K356R enhances polymerase activity alone and with
PB2-E627K in human cells. RNP polymerase activity has been
shown to catalyze viral transcription and genomic replication,
which correlate with viral replication and pathogenicity in the
host (15).We examined the effect of PA-356RonRNPpolymerase
activity in human 293T cells (Fig. 3A). PA-K356R showed a sig-
nificant increase in polymerase activity in 293T cells at 33°C and
37°C (P 0.05) compared to the wild-type polymerase complex.
As mutations PA-K356R and PB2-E627K coexist in avian H9N2
andhumanH7N9/H10N8 viruses, we also examined the polymer-
ase activity of the combined PA-K356R/PB2-E627K mutations.
Mutation PB2-E627K alone or double mutation PA-K356R/PB2-
E627K induced higher polymerase activity than did PA-K356R;
the PA-K356R/PB2-E627K double mutation elicited the highest
polymerase activity (P 0.05) (Fig. 3A). The observed increase in
the polymerase activity of the mutated complexes might be asso-
ciated with altered protein production. Western blotting with
protein lysates derived from 293T cells transfected with RNP plas-
mids indicated that PA and PB2 mutations did not quantitatively
affect protein expression (Fig. 3A). Thus, the enhanced polymer-
ase activities detected with PA and PB2 mutations were likely due
to increased enzymatic activities. In contrast to the results with
293T cells, RNP polymerase activity remained unchanged with all
three mutations (PA-K356R, PB2-E627K, and PA-K356R/PB2-
E627K) in DF-1 cells at 37°C and 39°C (Fig. 3B). These results
demonstrate that PA-K356R is a species-specific regulator that
enhances the polymerase activity of avianH9N2 viruses in human
293T but not chicken DF-1 cells and exhibits cooperative poly-
merase enhancement with mutation PB2-E627K.
PA-K356R augments viral transcription and genomic repli-
cation. The performance of viral RNP polymerase in viral tran-
scription (mRNA) and genomic replication (vRNA) was evalu-
ated in A549 cells with the WT, PA-K356R, PB2-E627K, and
doublemutant PA-K356R/PB2-E627KH9N2 viruses at 2, 6, 8, 24,
and 48 hpi (Fig. 4). qRT-PCR analyses with mRNA- or vRNA-
specific primers indicated that all three mutant viruses produced
significantly higher levels of both viral M1 and NP mRNA and
vRNA at 2 hpi than did the WT H9N2 virus (P  0.05). The
promotional effect of PA-K356R was similar to that of PB2-
E627K. Combined PA-K356R and PB2-E627Kmutations showed
cooperativity at 6 and 8 hpi to significantly increase viral tran-
scription and replication (P 0.05). These data demonstrate that
PA-356R (like PB2-627K) in avian H9N2 viruses increases viral
transcription and replication in human A549 cells.
PA-K356R enhances production of H9N2 virus in mamma-
lian cells. To compare the replication of H9N2 viruses with a
PA-K356R, PB2-E627K, and combined PA-K356R/PB2-E627K
mutations, we determined theirmultistep replication kinetics at 6,
12, 24, 36, 48, 60, and 72 hpi in MDCK and A549 cells infected at
MOIs of 0.001 and 0.01, respectively. All three mutant viruses
showed similar virus outputs that were significantly higher (up to
10-fold higher) than those from the wild-type virus over 12 to 36
hpi (P  0.05) (Fig. 5A and B). To determine if increased virus
replication took place early during infection, we conducted assays
of single-replication-cycle kinetics at an MOI of 1.0 over 12 hpi
(Fig. 5C andD). All threemutant viruses generatedmore progeny
virus (up to nearly 100-fold higher) than did thewild-type virus in
MDCK and A549 cells. The H9N2 virus with double mutation
PA-K356R/PB2-E627K showed a sustained elevation of virus out-
put that was higher than the output from the PB2-E627K mutant
in A549 cells at 6, 8, and 12 hpi (Fig. 5D). Taken together, these
data show that the PA-K356R mutation alone or in combination
with PB2-E627K enhances the progeny output of H9N2 virus in
MDCK and A549 cells, particularly during the initial 12 h of in-
fection.
FIG 4 Quantitative estimation of mRNA and vRNA levels of M1 and NP in
H9N2 virus-infected A549 cells. A549 cells were infected with the indicated
H9N2mutant viruses at anMOI of 1.0 for 2, 6, and 8 h or at anMOI of 0.01 for
24 and 48 h. The mRNA and vRNA expression levels of M1 and NP from
mutant viruses are expressed as fold changes in relation to thewild-type group.
Data are presented as means
 standard deviations of results from three inde-
pendent experiments. * indicates that the value is significantly different from
that for the wild-type virus (P 0.05 as determined by ANOVA), and # indi-
cates that the value is significantly different from that for the virus with single
mutation PB2-E627K (P 0.05 as determined by ANOVA).
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PA-K356R increases pathogenicity and replication of H9N2
virus in mice. We further determined the functionality of PA-
K356R alone or in conjunction with PB2-E627K in pathogenicity
and replication in mice. All mice infected with mutant viruses
(harboring PA-K356R, PB2-E627K, or both) at 106 TCID50 died
by 8 dpi (Fig. 6A). With the PA-K356R/PB2-E627K double mu-
tant virus, complete lethality occurred sooner, at 5 dpi. In con-
trast, all mice infected with the wild-type virus survived infection.
Expectedly, the weight loss of infected mice corresponded to rel-
ative virus lethality (Fig. 6B). Viruses with the PB2-E627K or PA-
K356R/PB2-E627K mutation produced the greatest weight loss.
Lung tissues were collected at 5 dpi for histopathology. Severe
interstitial pneumonia and bronchopneumonia, characterized by
alveolar interstitial consolidation and extensive inflammatory cell
FIG 5 Virus output of mutant and wild-type H9N2 viruses from infected MDCK and A549 cells. (A and B) Multistep growth curves of H9N2 viruses were
determined in MDCK (A) and A549 (B) cells. MDCK and A549 cells were inoculated with viruses at MOIs of 0.001 and 0.01, respectively. (C and D) Single
replication cycles of H9N2 viruses were also examined inMDCK (C) and A549 cells (D) at anMOI of 1.0. The supernatants of infected cells were collected at the
indicated time points. The virus titers aremeans
 standard deviations (n 3). * indicates that the value is significantly different from that for thewild-type virus
(P 0.05 as determined by ANOVA), and # indicates that the value is significantly different from that for the virus with single mutation PB2-E627K (P 0.05
by ANOVA).
FIG 6 Pathogenicity of H9N2 mutant viruses in mice. Five BALB/c mice per group were inoculated with 106 TCID50 of the indicated viruses or mock infected
with PBS. (A) Survival rate of mice. Mice that lost30% of their baseline weight were euthanized. (B) Body weight changes of mice. The values represent the
average body weights compared to the baseline weight 
 standard deviations from five mice. (C) Hematoxylin- and eosin-stained lung sections from mice
infected with the indicated viruses at 5 dpi. Bar, 200 m.
Xu et al.
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infiltration, were evident in PA-K356R, PB2-E627K, and PA-
K356R/PB2-E627K virus-infected lung sections (Fig. 6C). The
most severe pathology was observed for the PA-K356R/PB2-
E627K virus-infected group. In summary, PA-356R in the H9N2
virus caused severe pathology similar to that of PB2-627K, with a
further increase in severity being evident when both mutations
were present in the virus.
Virus titers in nasal turbinates and lungs from infected mice
(three in each group) were evaluated at 1, 3, and 5 dpi (Table 1).
Consistent with the pathogenicity results, the virus carrying com-
bined mutation PA-K356R/PB2-E627K produced the highest ti-
ters in the nasal turbinates and lungs. The PA-K356R and PB2-
E627K single mutants generated significantly higher titers than
did the wild-type virus at 3 and/or 5 dpi (P 0.05). Collectively,
PA-356R alone or cooperatively with PB2-627K in theH9N2 virus
conferred elevated pathogenicity and virus replication in mice.
H9N2 virus with the PA-K356R mutation induces an ele-
vated proinflammatory response in mice. Severe influenza virus
infection in humans and animal models is associated with abnor-
mally elevated pulmonary expression levels of proinflammatory
cytokines such as TNF-	, IL-6, and IL-1 (32–34). To compare
the proinflammatory impacts of PA-K356R, PB2-E627K, and PA-
K356R/PB2-E62K, we determined the protein expression levels of
the three cytokines in the lungs of infected mice at 1, 3, and 5 dpi
(Fig. 7). All three mutant viruses induced higher levels of produc-
tion of TNF-	, IL-6, and IL-1 over all three time points than did
the wild-type virus (P  0.05). Furthermore, the PA-356R/PB2-
627K mutant elicited higher levels of production of TNF-	 and
IL-6 at 1 dpi and of IL-1 at 5 dpi than did the PB2-E627K virus
(P  0.05) (Fig. 7). These results show that individual and com-
bined substitutions of PA-K356R and PB2-E627K in H9N2 vi-
ruses increase proinflammation inmice, consistent with increased
pathogenicity and virus replication.
DISCUSSION
Adaptive mutations in PA proteins of AIVs are recognized as be-
ing crucial for cross-species transmission tomammals (35). In the
present study, we characterized and compared one such adaptive
mutation, PA-K356R, in an avian H9N2 virus, which promoted
PA nuclear accumulation and viral polymerase activity in mam-
TABLE 1 Average virus titers in organs of infected mice
Virus
Avg virus titer (mean log10 TCID50/ml
 SD)
a
1 dpi 3 dpi 5 dpi
Nasal turbinate Lung Nasal turbinate Lung Nasal turbinate Lung
Wild type 2.08
 0.29 3.08
 0.58 4.12
 0.38 5.83
 0.38 3.42
 0.14 5.58
 0.14
PA-K356R 2.33
 0.14 3.33
 0.14 4.67
 0.14 6.25
 0.43 4.25
 0.66* 6.42
 0.58*
PB2-E627K 2.42
 0.14 3.50
 0.25 4.83
 0.38 6.75
 0* 4.75
 0.66* 6.42
 0.58*
PA-K356R/PB2-E627K 2.67
 0.14 3.83
 0.38 5.83
 0.14*# 6.83
 0.38* 5.08
 0.29* 6.50
 0.25*
a Lower limits of detection were 101.25 TCID50/ml for nasal turbinates or lungs. * indicates that the virus titer of the corresponding mutant strain was significantly higher than that
of the wild-type virus, and # indicates that the virus titer of the corresponding mutant strain was significantly higher than that of the PB2-E627K virus, with a P value of0.05, as
determined by one-way ANOVA.
FIG 7 Detection of cytokine proteins in lungs of mice infected with H9N2 mutant viruses. Nine mice per group were either inoculated with 106 TCID50 of the
indicated mutant viruses or mock infected with PBS, and protein levels of cytokines in the lungs of three infected mice were determined at 1, 3, and 5 dpi. Data
are presented as means
 standard deviations of results from three independent experiments. * indicates that the value is significantly different from that for the
wild-type virus (P  0.05 as determined by ANOVA), and # indicates that the value is significantly different from that for the virus with single mutation
PB2-E627K (P 0.05 as determined by ANOVA).
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malian cells. Importantly, mice infected with this mutant PA-
K356R virus exhibited increased virus output, severe lung pathol-
ogy, and an elevated proinflammatory cytokine response that
culminated in complete lethality by 8 dpi.
The PA protein, which is 716 amino acids long, is the third
subunit of the viral polymerase complex. The functions of the PA
protein are associated with its interactions with the PB1 and PB2
proteins and with its endonuclease and protease activities (35). It
can be cleaved by limited tryptic digestion into N-terminal
(PA-N) and C-terminal (PA-C) domains (36). Known mamma-
lian adaptivemutations are foundmainly in the PA-N region (35),
with some being found in the PA-C domain, such as PA-T552S in
human isolates (25, 37). PA-356 is located in the PA-C domain
and is close to the loop spanning amino acid positions 350 to 355
(i.e., the 350–355 loop) (38). The loops from two PA monomers
are antiparallel to each other and have been proposed to form
multiple interactions (38). Besides PA-356, residues located in the
350–355 loop are found to confer mammalian tropism and
pathogenicity. For example, the I353R mutation is a primary de-
terminant of enhanced polymerase activity, virus replication, and
increased virulence of an avian H5N1 virus strain in a mouse
model (39). Liedmann et al. found that a singlemutation (K351E)
in the PA protein contributes to the inhibition of beta interferon
(IFN-) induction and virulence of the A/Puerto Rico/8/1934 (A/
PR/8/34) virus in mice (40). Therefore, the 350–355 loop and its
proximal residues may perform a critical role in determining
cross-species transmission and mammalian adaptation.
Neumann et al. recently identified a number of critical amino
acid changes in the PA gene of ancestral H9N2 lineages, including
the PA-K356R mutation, that contributed to the emergent avian
H7N9 viruses that readily cause severe human infections (26).
However, in the A/Anhui/1/2013 (H7N9) virus background, the
reverse (avian-like) mutant PA-R356K appears to have little effect
on viral polymerase activity and virulence in vitro and in vivo (28).
TheH7N9 human isolate used in that studywould have contained
multiple mammalian adaptive markers, including the well-char-
acterized PB2-627Kmarker. In the present study, we used an ear-
lier wild-type H9N2 isolate to provide a viral background with no
knownmammalian adaptivemarkers. Indeed, the PA-K356Rmu-
tation in an H9N2 virus background exhibited significant in-
creases in virus replication and pathogenicity inmice, underlining
the functional significance of this mutation.
To better understand the natural selection of mutation PA-
K356R, we investigated its emergence and prevalence in avian and
human influenza viruses. We found that PA-356K and PA-356R
are presently conserved in avian (except for H9N2) and human
viruses, respectively, suggesting that this residue has a critical role
in host species tropism. Since the first avian-origin H1N1 virus
entered humans in 1918 to become established as a human H1N1
seasonal virus, its avian-like signature PA-356K has been gradu-
ally replaced with the human-like PA-356R mutation. Strikingly,
in the last few years, the same human-like residue PA-356R has
emerged and become predominant in avian H9N2 viruses in
chickens. The PA-356R signature, along with the well-known
mammalian adaptive marker PB2-E627K, has further spread to
avianH7N9 andH10N8 reassortants, which harbor the PAgene of
H9N2 origin. The functionality of the PA-K356R mutation ap-
pears cooperative with PB2-E627K. These mutations individually
and collectively increased viral transcription and replication,
progeny virus production, and severity of infection inmammalian
cells and mice. Conceivably, viruses that harbor both mutations
could pose a severe risk to human health. Indeed, hundreds of
severe human cases of H7N9 and several H10N8 virus infections
were recently documented (2–4). The combined mutations PA-
356R and PB2-627K in H7N9 and H10N8 viruses appear to act in
concert to enhance infection and pathogenicity in humans.
In this study, we found that the PA-K356R mutation could
contribute to the possible transfer from avian-like tropism to hu-
man-like tropism. We found that this mutation increased viral
replication and pathogenicity in mice. However, the PA-K356R
mutation did not alter viral polymerase activity in avian cells, sug-
gesting that it could be a mammalian species-specific regulator.
There is epidemiological evidence of avian viruseswithmutations,
akin to PA-K356R, that confer mammalian tropism and that have
emerged or becomepredominant in avian strains before transmis-
sion to mammals. Similarly to PA-K356R, hemagglutinin (HA)
mutation Q226L, which is a human-like mutation and confers
binding to the human-like sialic acid (SA) 	-2,6-Gal receptor, has
presently become predominant in H9N2 avian viruses since ap-
pearing in the 1990s (1). Wan and Perez demonstrated that an
HA-Q226Lmutant promotes both cell tropism and replication of
H9N2 viruses in human airway epithelial cells (41). However,
Vines et al. showed that this single residue has little or no effect on
viral replication in ducks (42). Likewise, the PA-I353R mutation
in avian H5N1 viruses contributes to viral infection only in mice
but not in avian hosts (39, 43). Thus, thesemutations also seem to
be mammal-specific regulators. Some mutations, however, are
found to confer improved infection of both birds and mammals.
For example, our previous study revealed that H9N2 viruses with
an HA-A316S substitution and/or a shorter neuraminidase (NA)
stalk are predominantly prevalent in avian strains and can increase
virulence in chickens and mice (44). Thus, emerging or even es-
tablished mutations in avian strains can exhibit increased viral
infectivity in mammalian host species, which in turn could be
different in avian species. The prevalence of these mammalian
tropism mutations in large avian populations poses great con-
cerns to public health. In summary, PA-K356R behaves as amam-
malian tropismmutation,which, alongwith othermutations such
as PB2-E627K, could render avian H9N2 viruses or their reassor-
tants more adapted to human infection.
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